Sir Marc Feldmann, who was recently appointed a Senior Research Fellow at Somerville, is one of the recipients of the 2014 Canada Gairdner International Awards, often seen as a predictor for the Nobel Prize for Medicine.
Sir Marc is head of Oxford’s Kennedy Institute of Rheumatology. He received his award alongside research colleague Sir Ravinder Nath Maini, a Visiting Professor at the Institute, “for the discovery of anti-TNF therapy for the treatment of rheumatoid arthritis and other inflammatory diseases”.